Bharat Biotech releases Phase-3 trials data of Covaxin: Indian-made vaccine 77.8% effective against mild cases, 93% against severe cases
Bharat Biotech announced efficacy analysis data from Phase-3 clinical trials of Covaxin, proved to be highly effective against severe cases of COVID-19